|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07D 213/73 | (2006.01) |
| A61K 31/4412 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 29/00 | (2006.01) |
| (11) | Number of the document | 3222616 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17168533.2 |
| Date of filing the European patent application | 2013-10-15 | |
| (97) | Date of publication of the European application | 2017-09-27 |
| (45) | Date of publication and mention of the grant of the patent | 2019-07-17 |
| (46) | Date of publication of the claims translation | 2019-09-10 |
| (30) | Number | Date | Country code |
| 201218640 | 2012-10-17 | GB | |
| 201306881 | 2013-04-16 | GB |
| (72) |
PINTAT, Stéphane, GB
DAVIES, Stephen, John, GB
MOFFAT, David, Festus, Charles, GB
|
| (73) |
MACROPHAGE PHARMA LIMITED,
St. Stephens House Arthur Road, Windsor, Berkshire SL4 1RU,
GB
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | N-[2-{4-[6-amino-5-(2,4-difluorbenzoil)-2-oksopiridin-1(2H)-il]-3,5-difluorfenil}etil]-L-alaninas ir jo tret-butilo esteris |
| N-[2-{4-[6-AMINO-5-(2,4-DIFLUOROBENZOYL)-2-OXOPYRIDIN-1(2H)-YL]-3,5-DIFLUOROPHENYL}ETHYL]-L-ALANINE AND THE TERBUTYL ESTER THEREOF |
| Payment date | Validity (years) | Amount | |
| 2021-09-17 | 9 | 208.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2022-10-15 |